Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye

@inproceedings{Ueda2015EffectivenessAR,
  title={Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye},
  author={Kaori Ueda and Wataru Matsumiya and Keiko Otsuka and Yoshifumi Maeda and Takayuki Nagai and Makoto Nakamura},
  booktitle={BMC Ophthalmology},
  year={2015}
}
BackgroundRebamipide with mucin secretagogue activity was recently approved for the treatment of dry eye. The efficacy and safety in the treatment of rebamipide were shown in two pivotal clinical trials. It was the aim of this study to evaluate the effect of 2 % rebamipide ophthalmic suspension in patients with dry eye and analyze relevant factors for favorable effects of rebamipide in clinical practice.MethodsThis was a retrospective cohort study of 48 eyes from 24 patients with dry eye… CONTINUE READING
7
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Medical Treatment for Dry Eye in Japan.

  • Investigative ophthalmology & visual science
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Comparison of Tear Meniscus Height after Different Methods of Fluorescein Staining

Y Kanaya, Y Hori, +3 authors T. Maeno
  • J Eye
  • 2013
VIEW 1 EXCERPT

Rebamipide Ophthalmic Suspension Phase 3 Study Group

S Kinoshita, K Oshiden, +3 authors N. Yokoi
  • Ophthalmology
  • 2013

Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.

  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2013
VIEW 1 EXCERPT

Rebamipide Ophthalmic Suspension Phase II Study Group

S Kinoshita, S Awamura, +3 authors N. Yokoi
  • Ophthalmology
  • 2012
VIEW 1 EXCERPT